Neuronetics, Inc. (STIM)
1.885
-0.06
(-3.33%)
USD |
NASDAQ |
Oct 16, 16:00
1.885
0.00 (0.00%)
After-Hours: 20:00
Neuronetics Gross Profit Margin (Quarterly) : 50.09% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 50.09% |
| March 31, 2026 | 44.72% |
| December 31, 2025 | 50.99% |
| September 30, 2025 | 43.49% |
| June 30, 2025 | 44.23% |
| March 31, 2025 | 46.37% |
| December 31, 2024 | 64.25% |
| September 30, 2024 | 72.80% |
| June 30, 2024 | 70.66% |
| March 31, 2024 | 71.93% |
| December 31, 2023 | 75.16% |
| September 30, 2023 | 62.99% |
| June 30, 2023 | 69.77% |
| March 31, 2023 | 70.01% |
| December 31, 2022 | 72.56% |
| September 30, 2022 | 78.36% |
| June 30, 2022 | 75.26% |
| March 31, 2022 | 75.42% |
| Date | Value |
|---|---|
| December 31, 2021 | 74.50% |
| September 30, 2021 | 75.65% |
| June 30, 2021 | 78.73% |
| March 31, 2021 | 79.64% |
| December 31, 2020 | 74.56% |
| September 30, 2020 | 76.99% |
| June 30, 2020 | 73.76% |
| March 31, 2020 | 72.88% |
| December 31, 2019 | 75.69% |
| September 30, 2019 | 73.80% |
| June 30, 2019 | 74.83% |
| March 31, 2019 | 77.95% |
| December 31, 2018 | 76.26% |
| September 30, 2018 | 77.91% |
| June 30, 2018 | 75.51% |
| March 31, 2018 | 75.80% |
| December 31, 2017 | 75.58% |
| September 30, 2017 | 74.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| INVO Fertility, Inc. | 28.37% |
| Acadia Healthcare Co., Inc. | 16.58% |
| U.S. Physical Therapy, Inc. | 17.81% |
| Sanara MedTech, Inc. | 90.76% |
| Intelligent Bio Solutions, Inc. | 21.68% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -120.7% |
| Return on Assets | -22.73% |
| Return on Invested Capital | -27.48% |
| Profit Margin (Quarterly) | -8.33% |
| Operating Margin (Quarterly) | -3.61% |
| Return on Net Operating Assets | -31.94% |